| X23-10-ZQ325 |
JAK inhibitor JAK/HDAC-IN-1, Purity ≥98%
|
|
| X23-10-ZQ351 |
JAK inhibitor 1,2,3,4,5,6-Hexabromocyclohexane, Purity ≥98%
|
|
| X23-10-ZQ352 |
JAK inhibitor Abrocitinib, Purity ≥98%
|
|
| X23-10-ZQ355 |
JAK inhibitor AZ-3, Purity ≥98%
|
|
| X23-10-ZQ356 |
JAK inhibitor AZ-960, Purity ≥98%
|
|
| X23-10-ZQ357 |
JAK inhibitor AZD1480, Purity ≥98%
|
|
| X23-10-ZQ358 |
JAK inhibitor Baricitinib, Purity ≥98%
|
|
| X23-10-ZQ359 |
JAK inhibitor Baricitinib phosphate, Purity ≥98%
|
|
| X23-10-ZQ360 |
JAK inhibitor BD750, Purity ≥98%
|
|
| X23-10-ZQ361 |
JAK inhibitor BMS-066, Purity ≥98%
|
|
| X23-10-ZQ362 |
JAK inhibitor BMS-911543, Purity ≥98%
|
|
| X23-10-ZQ363 |
JAK inhibitor BMS-986165, Purity ≥98%
|
|
| X23-10-ZQ364 |
JAK inhibitor CEP33779, Purity ≥98%
|
|
| X23-10-ZQ365 |
JAK inhibitor Cercosporamide, Purity ≥98%
|
|
| X23-10-ZQ366 |
JAK inhibitor Cerdulatinib, Purity ≥98%
|
|
| X23-10-ZQ367 |
JAK inhibitor CHZ868, Purity ≥98%
|
|
| X23-10-ZQ368 |
JAK inhibitor Tofacitinib citrate, Purity ≥98%
|
|
| X23-10-ZQ369 |
JAK inhibitor Cucurbitacin I, Purity ≥98%
|
|
| X23-10-ZQ371 |
JAK inhibitor Momelotinib, Purity ≥98%
|
|
| X23-10-ZQ372 |
JAK inhibitor CYT387 sulfate salt, Purity ≥98%
|
|
| X23-10-ZQ373 |
JAK inhibitor Decernotinib, Purity ≥98%
|
|
| X23-10-ZQ374 |
JAK inhibitor Delgocitinib, Purity ≥98%
|
|
| X23-10-ZQ375 |
JAK inhibitor Filgotinib, Purity ≥98%
|
|
| X23-10-ZQ376 |
JAK inhibitor FLLL32, Purity ≥98%
|
|
| X23-10-ZQ377 |
JAK inhibitor FM-381, Purity ≥98%
|
|
| X23-10-ZQ378 |
JAK inhibitor GLPG0634, Purity ≥98%
|
|
| X23-10-ZQ380 |
JAK inhibitor Gusacitinib, Purity ≥98%
|
|
| X23-10-ZQ381 |
JAK inhibitor Ruxolitinib, Purity ≥98%
|
|
| X23-10-ZQ382 |
JAK inhibitor Itacitinib, Purity ≥98%
|
|
| X23-10-ZQ383 |
JAK inhibitor JAK-IN-1, Purity ≥98%
|
|
| X23-10-ZQ384 |
JAK inhibitor JAK-IN-3, Purity ≥98%
|
|
| X23-10-ZQ385 |
JAK inhibitor JAK-IN-4, Purity ≥98%
|
|
| X23-10-ZQ386 |
JAK inhibitor JAK-IN-5, Purity ≥98%
|
|
| X23-10-ZQ387 |
JAK inhibitor JAK1-IN-3, Purity ≥98%
|
|
| X23-10-ZQ388 |
JAK inhibitor JAK1-IN-4, Purity ≥98%
|
|
| X23-10-ZQ389 |
JAK inhibitor JAK1-IN-7, Purity ≥98%
|
|
| X23-10-ZQ390 |
JAK inhibitor JAK2-IN-4, Purity ≥98%
|
|
| X23-10-ZQ391 |
JAK3 covalent inhibitor-1, Purity ≥98%
|
|
| X23-10-ZQ392 |
JAK inhibitor JAK3-IN-1, Purity ≥98%
|
|
| X23-10-ZQ393 |
JAK inhibitor JAK3-IN-2, Purity ≥98%
|
|
